Response to Letter to the Editor on "A Prospective Double-Blind Placebo Controlled Trial of Topical Tranexamic Acid in Total Knee Arthroplasty"

J Arthroplasty. 2020 Apr;35(4):1161-1162. doi: 10.1016/j.arth.2019.12.018. Epub 2019 Dec 14.

Authors

Andrew G Georgiadis¹, Stephanie J Muh², Craig D Silverton², Robb M Weir², Michael W Laker³

Affiliations

¹ Department of Orthopaedic Surgery, Gillette Children's Specialty Healthcare, St. Paul, MN; Department of Orthopedics, University of Minnesota, Minneapolis, MN.
² Department of Orthopaedic Surgery, Henry Ford Hospital, Detroit, MI.
³ Birmingham Integrowth Orthopedics, Novi, MI.

PMID: 31902613
DOI: 10.1016/j.arth.2019.12.018

No abstract available

Publication types

Letter
Comment

MeSH terms

Antifibrinolytic Agents*
Arthroplasty, Replacement, Knee* / adverse effects
Blood Loss, Surgical
Double-Blind Method
Humans
Prospective Studies
Tranexamic Acid*

Substances

Antifibrinolytic Agents
Tranexamic Acid